Axsome Therapeutics Inc (AXSM)
76.54
-0.82
(-1.05%)
USD |
NASDAQ |
May 17, 16:00
76.54
0.00 (0.00%)
After-Hours: 20:00
Axsome Therapeutics Cash from Investing (Quarterly): -0.098M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.098M |
| December 31, 2023 | -0.007M |
| September 30, 2023 | -0.371M |
| June 30, 2023 | -0.133M |
| March 31, 2023 | -0.071M |
| December 31, 2022 | -0.181M |
| September 30, 2022 | -0.066M |
| June 30, 2022 | -53.24M |
| March 31, 2022 | -0.214M |
| December 31, 2021 | -0.0005M |
| September 30, 2021 | -0.2587M |
| June 30, 2021 | -0.0189M |
| March 31, 2021 | -0.03M |
| December 31, 2020 | -0.0203M |
| September 30, 2020 | -0.0148M |
| June 30, 2020 | -0.0014M |
| March 31, 2020 | -0.0093M |
| December 31, 2019 | -0.0015M |
| September 30, 2019 | -0.0032M |
| Date | Value |
|---|---|
| June 30, 2019 | -0.0115M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -0.0085M |
| June 30, 2018 | -0.0096M |
| March 31, 2018 | -0.0146M |
| December 31, 2017 | -0.00 |
| September 30, 2017 | -0.0036M |
| June 30, 2017 | -0.0034M |
| March 31, 2017 | -0.0029M |
| December 31, 2016 | -0.0061M |
| September 30, 2016 | -0.0763M |
| June 30, 2016 | -0.0116M |
| March 31, 2016 | -0.0107M |
| December 31, 2015 | -0.0041M |
| September 30, 2015 | -0.0044M |
| June 30, 2015 | -0.0014M |
| March 31, 2015 | -0.0103M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-53.24M
Minimum
Jun 2022
-0.0005M
Maximum
Dec 2021
-2.738M
Average
-0.0251M
Median
Cash from Investing (Quarterly) Benchmarks
| Krystal Biotech Inc | -25.98M |
| Catalyst Pharmaceuticals Inc | -0.199M |
| Vertex Pharmaceuticals Inc | -2.136B |
| Vistagen Therapeutics Inc | -0.0323M |
| ADMA Biologics Inc | -2.362M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -53.47M |
| Cash from Financing (Quarterly) | -1.187M |
| Free Cash Flow | -193.34M |
| Free Cash Flow Per Share (Quarterly) | -1.130 |
| Free Cash Flow to Equity (Quarterly) | -54.18M |
| Free Cash Flow to Firm (Quarterly) | -52.48M |
| Free Cash Flow Yield | -5.45% |